A Texas A&M University former student’s startup, Spark Biomedical, was awarded $50,000 as the winner of the 2019 Texas A&M New Ventures Competition (TNVC) hosted by the Texas A&M Engineering Experiment Station (TEES). Daniel Powell is CEO of the medical device company, which is developing noninvasive neurostimulation solutions for opioid withdrawal and addiction.

Partnership between Galen Data and Spark Biomedical strengthens their combined capability in support of connected medical devices and the ability to treat opioid withdrawal.